Our summer symposium will be held om Friday 26th July 10.00 - 13.00 Kennedy Lecture Theatre, UCL GOS ICH. The 2019 theme is "Genetic Therapies".
10am Welcome and Introduction
Professor Helen Cross OBE
Prince of Wales’ Chair of Childhood Epilepsy and Head of Developmental Neurosciences Programme, UCL GOS ICH
10.10 Professor Paul Gissen
Head of Genetic and Genomic Medicine Programme, UCL GOS ICH
Novel therapies in metabolic neurodegenerative disorders
10.35 Dr Rajvinder Karda
Research Associate, UCL Institute for Women’s Health
Gene Therapy for devastating childhood neurological disorders
11.00 Professor Simon Waddington
Professor of Gene Therapy, UCL Institute for Women’s Health
Fetal Gene Therapy
11.30 Refreshment break on the Balcony
12.00 Otto Wolff Lecture
Dr Ronald Cohn, President and CEO at the Hospital for Sick Children (SickKids Toronto)
Precision Child Health: A New Era on the Horizon
Dr. Ronald Cohn, MD, FACMG is the President and CEO of The Hospital for Sick Children (SickKids).
Dr. Ronald Cohn has served as President and CEO of the Hospital for Sick Children (SickKids) in Toronto, Canada since May 1st, 2019. Dr. Cohn joined SickKids in September 2012 as the Chief of the Division of Clinical and Metabolic Genetics, Co-Director of the Centre for Genetic Medicine, and Senior Scientist at the SickKids Research Institute. He became the Inaugural Women’s Auxiliary Chair in Clinical and Metabolic Genetics in April of 2013, and joined the department of Molecular Genetics at the University of Toronto. In 2016 he was appointed to the position of Chief of Paediatrics at SickKids, and Chair of Paediatrics at The University of Toronto.
Dr. Cohn received his medical degree from the University of Essen, Germany. After his postdoctoral fellowship at the Howard Hughes Medical Institute in the laboratory of Dr. Kevin Campbell, he moved to Baltimore where he was the first combined resident in paediatrics and genetics at the Johns Hopkins University. He subsequently joined the faculty of the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins where he became the director of the worlds' first multidisciplinary centre for Hypotonia, which has earned national and international recognition. Dr. Cohn was also the director of the medical genetics residency program at Johns Hopkins. He has received numerous awards including the David M. Kamsler Award for outstanding compassionate and expert care of pediatric patients in 2004; First Annual Harvard-Partners Center for Genetics and Genomics Award in Medical in 2006; and the NIH Young Innovator Award in 2008.
Over the last few years, Dr. Cohn has developed an interest in applying a concept of Precision Child Health to the care of children. His own research focusses on implementing genome editing technologies for the treatment of neurogenetic disorders.
All welcome to attend